Results 201 to 210 of about 30,301 (244)

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway. [PDF]

open access: yesCancer Gene Ther
Xie S   +18 more
europepmc   +1 more source

Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia. [PDF]

open access: yesCancer
Jen WY   +35 more
europepmc   +1 more source

Targeting Metabolic Dependencies in Acute Myeloid Leukemia: A Dual Strategy using Arsenic Trioxide and Artesunate

open access: yes
Balasundaram N   +12 more
europepmc   +1 more source

Arsenic trioxide

Expert Opinion on Pharmacotherapy, 2008
The ancient drug, arsenic, has remarkable efficacy in the treatment of relapsed acute promyelocytic leukemia (APL) and this success has led to exploration of its use in other malignancies.To provide an overview of the mechanism of action of arsenic and summarize its development in the treatment of APL and other malignant disorders.A 20-year search of ...
  +9 more sources

Home - About - Disclaimer - Privacy